✦ LIBER ✦

Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia

✍ Scribed by Shu-Wei Yang; Jennifer Smotryski; William T. McElroy; Zheng Tan; Ginny Ho; Deen Tulshian; William J. Greenlee; Mario Guzzi; Xiaoping Zhang; Deborra Mullins; Li Xiao; Alan Hruza; Tze-Ming Chan; Diane Rindgen; Carina Bleickardt; Robert Hodgson

Book ID: 113496368
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 977 KB
Volume: 22
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2011.11.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The discovery of potent, selective, and

The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia

✍ Ginny D. Ho; Shu-Wei Yang; Jennifer Smotryski; Ana Bercovici; Terry Nechuta; Eli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 932 KB

Discovery of Potent and Orally Active MT

Discovery of Potent and Orally Active MTP Inhibitors as Potential anti-Obesity Agents.

✍ Jin Li; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 12 KB 👁 2 views

Discovery of benzoylisoindolines as a no

Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors

✍ Emmanuel Pinard; Daniela Alberati; Markus Bender; Edilio Borroni; Virginie Brom; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Discovery of Orally Active 3-Pyridinyl-t

Discovery of Orally Active 3-Pyridinyl-tropane As a Potent Nociceptin Receptor Agonist for the Management of Cough

✍ Yang, Shu-Wei; Ho, Ginny; Tulshian, Deen; Greenlee, William J.; Anthes, John; Fe 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 858 KB

Discovery of Novel Benzoxazinones as Pot

Discovery of Novel Benzoxazinones as Potent and Orally Active Long Chain Fatty Acid Elongase 6 Inhibitors

✍ Mizutani, Takashi; Ishikawa, Shiho; Nagase, Tsuyoshi; Takahashi, Hidekazu; Fujim 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 953 KB

Hit-to-Lead Studies: The Discovery of Po

Hit-to-Lead Studies: The Discovery of Potent, Orally Active, Thiophenecarboxamide IKK-2 Inhibitors.

✍ Andrew Baxter; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 20 KB 👁 2 views